Psyence Biomedical Ltd Stock Market Value
| PBM Stock | USD 0.81 0.06 6.54% |
| Symbol | Psyence |
Psyence Biomedical Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Psyence Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Psyence Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Psyence Biomedical.
| 12/23/2025 |
| 01/22/2026 |
If you would invest 0.00 in Psyence Biomedical on December 23, 2025 and sell it all today you would earn a total of 0.00 from holding Psyence Biomedical Ltd or generate 0.0% return on investment in Psyence Biomedical over 30 days. Psyence Biomedical is related to or competes with Azitra, GT Biopharma, Revelation Biosciences, Protagenic Therapeutics, Lipella Pharmaceuticals, Elevai Labs, and Scisparc. Pacific Booker Minerals Inc. engages in the exploration of mineral properties in Canada. More
Psyence Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Psyence Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Psyence Biomedical Ltd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 96.66 | |||
| Value At Risk | (13.79) | |||
| Potential Upside | 8.1 |
Psyence Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Psyence Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Psyence Biomedical's standard deviation. In reality, there are many statistical measures that can use Psyence Biomedical historical prices to predict the future Psyence Biomedical's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (3.48) | |||
| Total Risk Alpha | (4.60) | |||
| Treynor Ratio | (0.49) |
Psyence Biomedical Backtested Returns
Psyence Biomedical maintains Sharpe Ratio (i.e., Efficiency) of -0.23, which implies the firm had a -0.23 % return per unit of risk over the last 3 months. Psyence Biomedical exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Psyence Biomedical's Risk Adjusted Performance of (0.15), coefficient of variation of (460.36), and Variance of 179.77 to confirm the risk estimate we provide. The company holds a Beta of 5.98, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Psyence Biomedical will likely underperform. At this point, Psyence Biomedical has a negative expected return of -3.21%. Please make sure to check Psyence Biomedical's variance, as well as the relationship between the potential upside and day median price , to decide if Psyence Biomedical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.51 |
Modest predictability
Psyence Biomedical Ltd has modest predictability. Overlapping area represents the amount of predictability between Psyence Biomedical time series from 23rd of December 2025 to 7th of January 2026 and 7th of January 2026 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Psyence Biomedical price movement. The serial correlation of 0.51 indicates that about 51.0% of current Psyence Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 2.59 |
Psyence Biomedical lagged returns against current returns
Autocorrelation, which is Psyence Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Psyence Biomedical's stock expected returns. We can calculate the autocorrelation of Psyence Biomedical returns to help us make a trade decision. For example, suppose you find that Psyence Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Psyence Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Psyence Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Psyence Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Psyence Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Psyence Biomedical Lagged Returns
When evaluating Psyence Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Psyence Biomedical stock have on its future price. Psyence Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Psyence Biomedical autocorrelation shows the relationship between Psyence Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Psyence Biomedical Ltd.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Psyence Biomedical Correlation, Psyence Biomedical Volatility and Psyence Biomedical Alpha and Beta module to complement your research on Psyence Biomedical. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Psyence Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.